These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 12559796

  • 1. Local and systemic immune response in nursing-home elderly following intranasal or intramuscular immunization with inactivated influenza vaccine.
    Muszkat M, Greenbaum E, Ben-Yehuda A, Oster M, Yeu'l E, Heimann S, Levy R, Friedman G, Zakay-Rones Z.
    Vaccine; 2003 Mar 07; 21(11-12):1180-6. PubMed ID: 12559796
    [Abstract] [Full Text] [Related]

  • 2. Serum and mucosal immunologic responses in children following the administration of a new inactivated intranasal anti-influenza vaccine.
    Greenbaum E, Furst A, Kiderman A, Stewart B, Levy R, Schlesinger M, Morag A, Zakay-Rones Z.
    J Med Virol; 2001 Sep 07; 65(1):178-84. PubMed ID: 11505461
    [Abstract] [Full Text] [Related]

  • 3. Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine.
    Greenbaum E, Engelhard D, Levy R, Schlezinger M, Morag A, Zakay-Rones Z.
    Vaccine; 2004 Jun 30; 22(20):2566-77. PubMed ID: 15193382
    [Abstract] [Full Text] [Related]

  • 4. Local and systemic immune response in community-dwelling elderly after intranasal or intramuscular immunization with inactivated influenza vaccine.
    Muszkat M, Yehuda AB, Schein MH, Friedlander Y, Naveh P, Greenbaum E, Schlesinger M, Levy R, Zakay-Rones Z, Friedman G.
    J Med Virol; 2000 May 30; 61(1):100-6. PubMed ID: 10745240
    [Abstract] [Full Text] [Related]

  • 5. Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers.
    Stephenson I, Zambon MC, Rudin A, Colegate A, Podda A, Bugarini R, Del Giudice G, Minutello A, Bonnington S, Holmgren J, Mills KH, Nicholson KG.
    J Virol; 2006 May 30; 80(10):4962-70. PubMed ID: 16641287
    [Abstract] [Full Text] [Related]

  • 6. Systemic and local antibody responses in elderly subjects given live or inactivated influenza A virus vaccines.
    Powers DC, Sears SD, Murphy BR, Thumar B, Clements ML.
    J Clin Microbiol; 1989 Dec 30; 27(12):2666-71. PubMed ID: 2592535
    [Abstract] [Full Text] [Related]

  • 7. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?
    Tamura S, Ainai A, Suzuki T, Kurata T, Hasegawa H.
    Jpn J Infect Dis; 2016 Dec 30; 69(3):165-79. PubMed ID: 27212584
    [Abstract] [Full Text] [Related]

  • 8. Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine.
    Clements ML, Murphy BR.
    J Clin Microbiol; 1986 Jan 30; 23(1):66-72. PubMed ID: 3700610
    [Abstract] [Full Text] [Related]

  • 9. Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine.
    Powers DC, Belshe RB.
    J Infect Dis; 1993 Mar 30; 167(3):584-92. PubMed ID: 8440930
    [Abstract] [Full Text] [Related]

  • 10. Alkyl polyglycoside, a highly promising adjuvant in intranasal split influenza vaccines.
    Wu H, Bao Y, Wang X, Zhou D, Wu W.
    Hum Vaccin Immunother; 2017 Jun 03; 13(6):1-9. PubMed ID: 28129034
    [Abstract] [Full Text] [Related]

  • 11. Response to influenza vaccination in community and in nursing home residing elderly: relation to clinical factors.
    Muszkat M, Friedman G, Dannenberg HD, Greenbaum E, Lipo M, Heymann Y, Zakay-Rones Z, Ben-Yehuda A.
    Exp Gerontol; 2003 Oct 03; 38(10):1199-203. PubMed ID: 14580873
    [Abstract] [Full Text] [Related]

  • 12. Induction of Local Secretory IgA and Multifunctional CD4⁺ T-helper Cells Following Intranasal Immunization with a H5N1 Whole Inactivated Influenza Virus Vaccine in BALB/c Mice.
    Trondsen M, Aqrawi LA, Zhou F, Pedersen G, Trieu MC, Zhou P, Cox RJ.
    Scand J Immunol; 2015 May 03; 81(5):305-17. PubMed ID: 25737202
    [Abstract] [Full Text] [Related]

  • 13. The humoral response to live and inactivated influenza vaccines administered alone and in combination to young adults and elderly.
    Stepanova L, Naykhin A, Kolmskog C, Jonson G, Barantceva I, Bichurina M, Kubar O, Linde A.
    J Clin Virol; 2002 Apr 03; 24(3):193-201. PubMed ID: 11856620
    [Abstract] [Full Text] [Related]

  • 14. Human immune responses elicited by an intranasal inactivated H5 influenza vaccine.
    Ainai A, van Riet E, Ito R, Ikeda K, Senchi K, Suzuki T, Tamura SI, Asanuma H, Odagiri T, Tashiro M, Kurata T, Multihartina P, Setiawaty V, Pangesti KNA, Hasegawa H.
    Microbiol Immunol; 2020 Apr 03; 64(4):313-325. PubMed ID: 31957054
    [Abstract] [Full Text] [Related]

  • 15. Safety of and serum antibody response to cold-recombinant influenza A and inactivated trivalent influenza virus vaccines in older adults with chronic diseases.
    Gorse GJ, Belshe RB, Munn NJ.
    J Clin Microbiol; 1986 Sep 03; 24(3):336-42. PubMed ID: 3531226
    [Abstract] [Full Text] [Related]

  • 16. In elderly persons live attenuated influenza A virus vaccines do not offer an advantage over inactivated virus vaccine in inducing serum or secretory antibodies or local immunologic memory.
    Powers DC, Fries LF, Murphy BR, Thumar B, Clements ML.
    J Clin Microbiol; 1991 Mar 03; 29(3):498-505. PubMed ID: 2037667
    [Abstract] [Full Text] [Related]

  • 17. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
    de Haan A, Haijema BJ, Voorn P, Meijerhof T, van Roosmalen ML, Leenhouts K.
    Vaccine; 2012 Jul 06; 30(32):4884-91. PubMed ID: 22537989
    [Abstract] [Full Text] [Related]

  • 18. Neuraminidase antibody response to inactivated influenza virus vaccine following intranasal and intramuscular vaccination.
    Muhamed G, Greenbaum E, Zakay-Rones Z.
    Isr Med Assoc J; 2006 Mar 06; 8(3):155-8. PubMed ID: 16599048
    [Abstract] [Full Text] [Related]

  • 19. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M, Velumani S, He F, Karuppannan AK, Geng GY, Yin LK, Kwang J.
    Virology; 2008 Oct 25; 380(2):412-20. PubMed ID: 18786689
    [Abstract] [Full Text] [Related]

  • 20. Human immune responses to influenza virus vaccines administered by systemic or mucosal routes.
    Moldoveanu Z, Clements ML, Prince SJ, Murphy BR, Mestecky J.
    Vaccine; 1995 Aug 25; 13(11):1006-12. PubMed ID: 8525683
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.